SSX2 and synovial sarcoma: These results show that SS18-SSX activity is also associated with enhanced H2AK119ub1 in human synovial sarcoma and suggest an autoregulatory mechanism in which the oncofusion can potentiate its own chromatin binding and therefore its oncogenic activity.